Categories
Nevin Manimala Statistics

Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain

Int J Dermatol. 2022 Dec 10. doi: 10.1111/ijd.16527. Online ahead of print.

NO ABSTRACT

PMID:36495585 | DOI:10.1111/ijd.16527

By Nevin Manimala

Portfolio Website for Nevin Manimala